Q3 2024 EPS Estimates for Option Care Health, Inc. Lowered by Analyst (NASDAQ:OPCH)

Option Care Health, Inc. (NASDAQ:OPCH) – Research analysts at William Blair lowered their Q3 2024 earnings estimates for shares of Option Care Health in a research report issued to clients and investors on Wednesday, April 24th. William Blair analyst M. Larew now expects that the company will earn $0.31 per share for the quarter, down from their previous forecast of $0.32. The consensus estimate for Option Care Health’s current full-year earnings is $1.18 per share. William Blair also issued estimates for Option Care Health’s Q4 2024 earnings at $0.35 EPS.

A number of other brokerages have also recently issued reports on OPCH. Jefferies Financial Group upped their target price on Option Care Health from $36.00 to $38.00 and gave the stock a “buy” rating in a research report on Monday, March 4th. Barrington Research reaffirmed an “outperform” rating and set a $38.00 price objective on shares of Option Care Health in a report on Wednesday.

Option Care Health Stock Performance

Shares of NASDAQ OPCH opened at $29.61 on Friday. The business’s 50-day simple moving average is $31.96 and its 200-day simple moving average is $31.48. The company has a debt-to-equity ratio of 0.74, a quick ratio of 1.33 and a current ratio of 1.77. Option Care Health has a 52 week low of $24.23 and a 52 week high of $35.74. The firm has a market cap of $5.15 billion, a price-to-earnings ratio of 19.48, a P/E/G ratio of 1.43 and a beta of 1.22.

Option Care Health (NASDAQ:OPCH) last posted its earnings results on Tuesday, April 23rd. The company reported $0.26 EPS for the quarter, topping the consensus estimate of $0.22 by $0.04. Option Care Health had a net margin of 6.15% and a return on equity of 18.92%. The firm had revenue of $1.15 billion for the quarter, compared to the consensus estimate of $1.10 billion. During the same period in the prior year, the business posted $0.21 earnings per share. The business’s quarterly revenue was up 12.8% on a year-over-year basis.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in OPCH. Vanguard Group Inc. increased its position in shares of Option Care Health by 1.6% during the fourth quarter. Vanguard Group Inc. now owns 19,626,205 shares of the company’s stock valued at $661,207,000 after purchasing an additional 306,853 shares during the period. Wellington Management Group LLP lifted its position in Option Care Health by 157.1% in the fourth quarter. Wellington Management Group LLP now owns 7,445,556 shares of the company’s stock worth $250,841,000 after purchasing an additional 4,549,164 shares during the period. Third Point LLC boosted its stake in Option Care Health by 55.7% during the third quarter. Third Point LLC now owns 5,450,659 shares of the company’s stock worth $176,329,000 after buying an additional 1,950,659 shares in the last quarter. Westfield Capital Management Co. LP increased its holdings in Option Care Health by 19.6% in the 4th quarter. Westfield Capital Management Co. LP now owns 4,482,732 shares of the company’s stock valued at $151,023,000 after buying an additional 735,344 shares during the period. Finally, FMR LLC raised its stake in shares of Option Care Health by 10.8% in the 3rd quarter. FMR LLC now owns 3,717,299 shares of the company’s stock valued at $120,255,000 after buying an additional 362,828 shares in the last quarter. Institutional investors own 98.05% of the company’s stock.

Insider Buying and Selling

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. acquired 35,000 shares of Option Care Health stock in a transaction dated Monday, February 26th. The stock was bought at an average cost of $31.55 per share, with a total value of $1,104,250.00. Following the completion of the transaction, the director now owns 269,528 shares of the company’s stock, valued at $8,503,608.40. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.64% of the stock is owned by insiders.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.